Recente behandelresultaten van uitgezaaid melanoom

Autor: van Zeijl, MCT, Van den Eertwegh, AJM, Wouters, MWJM, Jochems, A, Schouwenburg, MG, Haanen, JBAG, Aarts, MJ, van den Berkmortel, FWPJ, de Groot, JWB, Hospers, GAP, Kapiteijn, E, Koornstra, RH, Piersma, D, van Rijn, RS, Suijkerbuijk, KPM, ten Tije, AJ, van der Veldt, Astrid, Vreugdenhil, G, van der Hoeven, KJM

Publikováno v: Nederlands Tijdschrift voor Geneeskunde, 162:D2420. Bohn Stafleu van Loghum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::c0f75d05a21b410ea44f763521d221b2
https://pure.eur.nl/en/publications/7d05ac42-34e9-414d-85cc-276ea6280c0f

Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry.

Autor: Jochems A; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands. a.jochems@lumc.nl.; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands. a.jochems@lumc.nl., van der Kooij MK; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands., Fiocco M; Medical Statistics, Department of Biomedical Data Sciences, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands.; Mathematical Institute Leiden University, Niels Bohrweg 1, 2333 CA Leiden, The Netherlands., Schouwenburg MG; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands.; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands., Aarts MJ; Department of Medical Oncology, Maastricht University Medical Centre, P. Debyelaan 25, 6202 AZ Maastricht, The Netherlands., van Akkooi AC; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre, 6130 MB Sittard-Geleen, The Netherlands., Blank CU; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, VU Medical Centre, de Boelelaan 1117, 1081 HZ Amsterdam, The Netherlands., Franken MG; Department of Health Technology Assessment, Institute for Medical Technology Assessment and Erasmus School of Health Policy & Management, Erasmus University, Burgemeester Oudlaan 50, 3000 DR Rotterdam, The Netherlands., de Groot JB; Department of Medical Oncology, Isala Oncological Center, 8000 GK Zwolle, The Netherlands., Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Koornstra RH; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6500 HB Nijmegen, The Netherlands., Kruit WHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Molewaterplein 40, 3000 CA Rotterdam, The Netherlands., Louwman M; Netherlands Comprehensive Cancer Organisation, PO Box 19079, 3501 DB Utrecht, The Netherlands., Piersma D; Department of Medical Oncology, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands., van Rijn RS; Department of Medical Oncology, Medical Centre Leeuwarden, Henri Dunantweg 2, 8934 AD Leeuwarden, The Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands., Ten Tije AJ; Department of Medical Oncology, Amphia Ziekenhuis, Langendijk 175, 4819 EV Breda, The Netherlands., Vreugdenhil G; Department of Medical Oncology, Maxima Medisch Centrum, de Run 4600, 5500 MB Veldhoven, The Netherlands., Wouters MWJM; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van Zeijl MCT; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands.; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands., van der Hoeven KJM; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6500 HB Nijmegen, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, po box 9600, 2300 RC Leiden, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2019 Jul 18; Vol. 11 (7). Date of Electronic Publication: 2019 Jul 18.

Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands.

Autor: Jochems A; Department of Medical Oncology, Leiden University Medical Center.; Dutch Institute for Clinical Auditing, Leiden., Leeneman B; Department of Health Technology Assessment, Erasmus School of Health Policy & Management., Franken MG; Institute for Medical Technology Assessment, Erasmus University Rotterdam., Schouwenburg MG; Department of Medical Oncology, Leiden University Medical Center.; Dutch Institute for Clinical Auditing, Leiden., Aarts MJB; Department of Medical Oncology, Maastricht University Medical Center, Maastricht., van Akkooi ACJ; Departments of Surgical Oncology., van den Berkmortel FWPJ; Department of Internal Medicine, Zuyderland Medical Center Geleen, Heerlen., van den Eertwegh AJM; Dutch Institute for Clinical Auditing, Leiden.; Department of Medical Oncology, VU University Medical Center, Amsterdam., Groenewegen G; Department of Medical Oncology, University Medical Center Utrecht., de Groot JWB; Department of Medical Oncology, Isala, Zwolle., Haanen JBAG; Dutch Institute for Clinical Auditing, Leiden.; Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, Groningen., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center., Koornstra RH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen., Kruit WHJ; Department for Medical Oncology, Erasmus MC Cancer Institute, Rotterdam., Louwman MWJ; Netherlands Comprehensive Cancer Organisation, Utrecht., Piersma D; Department of Internal Medicine, Medical Spectrum Twente, Enschede., van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden., Ten Tije AJ; Department of Internal Medicine, Amphia Hospital, Breda., Vreugdenhil G; Department of Internal Medicine, Maxima Medical Center, Veldhoven, The Netherlands., Wouters MWJM; Dutch Institute for Clinical Auditing, Leiden.; Departments of Surgical Oncology., Uyl-de Groot CA; Department of Health Technology Assessment, Erasmus School of Health Policy & Management.; Institute for Medical Technology Assessment, Erasmus University Rotterdam., van der Hoeven KJM; Dutch Institute for Clinical Auditing, Leiden.; Department of Medical Oncology, Radboud University Medical Center, Nijmegen.

Publikováno v: Anti-cancer drugs [Anticancer Drugs] 2018 Jul; Vol. 29 (6), pp. 572-578.

Xerosis and pruritus as major EGFRI-associated adverse events.

Autor: Clabbers JMK; Department of Clinical Oncology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. juliamkclabbers@gmail.com., Boers-Doets CB; Department of Clinical Oncology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Gelderblom H; Department of Clinical Oncology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Stijnen T; Department of Medical Statistics and Bioinformatics, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Lacouture ME; Department of Medicine, Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., van der Hoeven KJM; Department of Clinical Oncology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, The Netherlands., Kaptein AA; Department of Medical Psychology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2016 Feb; Vol. 24 (2), pp. 513-521. Date of Electronic Publication: 2015 Jun 27.